Patent · US Active

Von willebrand factor variants having improved factor VIII binding affinity

US9458223B2 · kind B2 · utility

2Cited by

4References

20Claims

0Family size

Assignee

CSL Behring AG · DE

Inventors

Stefan Schulte · Marburg, DE
Thomas Weimer · Gladenbach, DE
Kay Hofmann

Key dates

Filing date	Feb 14, 2013
Grant date	Oct 4, 2016
Priority date	—
Expiry date	Feb 14, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a polypeptide comprising a modified von Willebrand Factor (VWF) having a higher Factor VIII binding affinity than non-modified VWF, its pharmaceutical use and method of its preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.